Dopesick
Overview
Dopesick delves into the origins of the devastating opioid crisis in America, spotlighting the pivotal role played by one pharmaceutical company. The narrative unfolds across various settings—from a struggling mining town in Virginia grappling with addiction to the corridors of the DEA and the luxurious offices of Manhattan's elite pharmaceutical executives. This gripping exploration reveals the complexities and far-reaching consequences of the epidemic, highlighting the personal and societal toll of addiction while shedding light on the failures of regulation and accountability in the pharmaceutical industry.
Episodes
-
1
First Bottle
Title: First Bottle Plot: Richard Sackler initiates the rollout of a groundbreaking pain relief medication. Meanwhile, a country physician discovers ...
-
2
Breakthrough Pain
Title: Pain Unveiled Plot: OxyContin has been introduced, but it now confronts an emerging challenge. Purdue's extensive power extends into Finch Cre...
-
3
The 5th Vital Sign
Doctor Finnix starts to reduce Betsy's OxyContin dosage, while Bridget witnesses firsthand the devastating effects the drug has on various communities...
-
4
Pseudo-Addiction
OxyContin sales soar, but concerns about abuse start to emerge. As prosecutors delve into allegations that are crucial to the drug's marketing strateg...
-
5
The Whistleblower
As the misuse of OxyContin continues to escalate nationwide, Bridget takes a stand against Purdue Pharmaceuticals. Meanwhile, Rick and Randy are on a ...
-
6
Hammer the Abusers
Richard Sackler confronts a dire threat to Purdue's financial health, while Bridget intensifies her battle with the FDA. Finnix reflects on his life c...
-
7
Black Box Warning
Richard Sackler and Purdue manipulate the system to keep their drug from facing restrictions. Meanwhile, Bridget makes significant progress in her mis...
-
8
The People vs. Purdue Pharma
Title: The People vs. Purdue Pharma Plot: Rick and Randy's pursuit of justice puts Richard Sackler's pharmaceutical empire at risk. In the meantim...
